Advertisement
Nasal glucagon can effectively and efficiently manage moderate or severe hypoglycemic episodes in real-world settings in adult patients with type 1 diabetes

ADA: Nasal Glucagon Feasible for Hypoglycemic Episodes

0
New product much easier to use than rescue injections, researcher says
Vitamin B6

Vitamin B6 Linked to Increased Risk of Hip Fracture

0
But no significant link for vitamin B12 and risk of hip fracture during trial and extended follow-up
Thirty million American adults (one in seven) have chronic kidney disease -- but many don't know it

CDC: Kidney Disease Affects One in Seven Americans

0
About 96 percent of those with early kidney disease don't know they have it
Depression affects about one-third of hospital patients and could slow their recovery

Review: Depression Screening As Inpatient Important, Feasible

0
Still, more research needed to determine effect of screening/treatment on patient outcomes
For most patients with non-insulin-treated type 2 diabetes

ADA: Glucose Self-Monitoring Often Lacks Benefit in T2DM

0
No significant improvements in hemoglobin A1c levels, HRQOL seen in non-insulin-treated cases
Medical students frequently do not achieve mastery of the skills necessary for accurate measurement of blood pressure

Medical Students Lacking Proficiency in BP Measurements

0
Among 159 medical students, a mean of 4.1 elements out of 11 were performed properly
From 1980 to 2015 the prevalence of obesity doubled in more than 70 countries

Obesity Prevalence Has Doubled in More Than 70 Countries

0
From 1980 to 2015 there was a continuous increase in obesity prevalence in most other countries
For patients with type 2 diabetes

Sitagliptin Stimulates Distal Tubular Natriuresis in T2DM

0
Increase in intact plasma SDF-1α1-67 and decrease in truncated plasma SDF-1α3-67
A new bill with tort reforms to protect Iowa physicians will take effect July 1

New Bill With Tort Reforms Will Protect Iowa Physicians

0
Reforms include limiting noneconomic damages for intangibles, stronger expert witness standards
Sodium-glucose cotransporter 2 inhibitors appear to increase the risk of diabetic ketoacidosis in patients with type 2 diabetes

SGLT2 Inhibitors Linked to Increased Risk of Ketoacidosis

0
Associated with approximately twice the risk of DKA compared to DPP4 inhibitors